LabCoro Raritan

LabCoro Raritan LaDUOrP 69 First Avenue Raritan, NJ 08869-1800 Phone: 877-547-6837 ‘,..-...t. a ',anon., 2 6 3-48 0-2797 -0 Pat ID t narrnl Numb... CNT31143092 Acctann Nunthei 31143092 Act aunt Ma. NIIIIIiICI 212-535-1012 Rini'', 70 'awn I an NaltDC EPSTEIN Account We, Woodson Merrell 44 E 67th St New York NY 10065 JEFFREY raftnehtitUkNanw I.,,,,ifly. ***-**-3348 PanmPhow 212-772-9416 Inafl'oltiat: Arc ilAtIDI 60/08/00 >atc of limb 01/20/53 \., M lawny RetneAtMle, 9 E 71ST ST NEW YORK NY 10065 AddamtnlInhantanim UPIN: A62553 Dale and lanes Collin:led 09/20/13 14:00 Date I iteicd 09/21/13 Date and law Reptn.:41 09/25/13 15:06ET Inn .ntaa Nam.: MERRELL , W Nil 1023153509 11k) m, tan Ill MERRELL let( ,lend MIR tipoProfile( CBC With Differential/Platelet: Comp. Metabol'c Panel (14); PE+InterplEfx IFE).S; Lyme Ab/Western Blot Reflex Iron and TIBC: Testosterone,Free+Weakly Bound; Prolactin; DHEA-Sulfate: Homocyst(e)ine, Plasma; C-Reactive Protein. Card'ac: Hemoglobin Ale; Prostate-Specific Ag, Serum TSH: Vitamin D, 25-Hydroxy: Uric Acid, Serum; GOT; Insulin; Ambiguous Test Order; Ferritin, Serum; Request Problem TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB N1414 LipoProfile LDL Particle Number LDL-P Lipids LDL-C LDL-C cannot be HDL-C Triglycerides Cholesterol, Total LDL and HDL Particles HDL-P (Total) Small LDL-P LDL Size 2111 High nmol/L Low Moderate Borderline-High High Very High NOTES: mg/dL calculated because triglycerides are > 28.7 1548 19.8 Low High High Low High Low Optimal Above optimal Borderline High Very high mg/dL mg/dL mg/dL umol/L nmol/L nm 01 <1000 01 < 1000 1000 - 1299 1300 - 1599 1600 - 2000 > 2000 <100 400 mg/dL. 100 130 160 *** INTERPRETATIVE INFORMATION*** PARTICLE CONCENTRATION AND SIZE <--Lower CVD Risk Higher CVD Risk--> LDL AND HDL PARTICLES Percentile in Reference Population HDL-P (total) High 75th 50th 25th Low >34.9 34.9 30.5 26.7 <26.7 • 100 - 129 - 159 - 189 • 189 >=40 <150 <200 >= 30.5 <= 527 > 20.5 01 01 01 01 01 01 01 01 01 EPSTEIN, JEFFREY 09/25/13 15:06 ET FINAL REPORT This document contains private and confidential health information protected by state and federal law If you have received this document in tam, please call 800-631-5250 I 263-480-2797-0 SeqS5515 Page 1 of 6 02004-13 Laboratory Corporation of America O Holdings All Rights Reserved DOC I Ver. 1.49 EFTA01108234 LabCorp NIICIII Name EPSTEIN, JEFFREY %man r.4 mho 263-480-2797-0 Ac“Ainl NtonIrr 31143092 Patient II) Control NumIxt CNT31143092 1)44r and lath Colleck1/44 09/20/13 14:00 Dare Repork4 09/25/13 %c, M Agt(Y/114/1)1 60/08/00 I ki,.. .• . 01/20/53 LabCorp Raritan 69 First Avenue Raritan, NJ 08869-1800 Phone: 877-547-6837 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Small LDL-P Low 25th 50th 75th High <117 117 527 839 >839 LDL Size <-Large (Pattern A)-> <-Small (Pattern B)-> 23.0 20.6 20.5 19.0 Insulin Resistance Score LP-IR Score 100 High <= 45 01 LP-IR Score is inaccurate if patient is non-fasting. The LP-IR Score combines information from lipoprotein particle concentration and size to give improved assessment of insulin resistance and diabetes risk. Small LDL-P, LDL Particle Size, HDL-Particle, and LP-IR Score have been validated by LipoScience but not cleared by US FDA; the clinical utility of these test results has not been fully established. INSULIN RESISTANCE MARKER 01 <--Insulin Sensitive Insulin Resistant--> Percentile in Reference Population Insulin Resistance Score LP-IR Score Low 25th 50th 75th High <27 27 45 63 >63 CBC With Differential/Platelet WBC 6.4 xl0E3/uL 3.4 10.8 02 RBC 5.24 x10E6/uL 4.14 5.80 02 Hemoglobin 15.3 g/dL 12.6 17.7 02 Hematocrit 43.9 37.5 51.0 02 MCV 84 fL 79 97 02 MCH 29.2 P9 26.6 33.0 02 MCHC 34.9 g/dL 31.5 35.7 02 RDW 14.3 12.3 15.4 02 Platelets 269 x10E3/uL 155 379 02 Neutrophils 56 40 74 02 Lymphs 31 14 46 02 Monocytes 8 4 12 02 Eos 4 0 5 02 Basos 1 0 3 02 Neutrophils (Absolute) 3.6 x10E3/uL 1.4 7.0 02 Lymphs (Absolute) 2.0 xl0E3/uL 0.7 3.1 02 Monocytes(Absolute) 0.5 x10E3/uL 0.1 0.9 02 Eos (Absolute) 0.3 x10E3/uL 0.0 0.4 02 Baso (Absolute) 0.1 x10E3/uL 0.0 0.2 02 Immature Granulocytes 0 0 2 02 Immature Grans (Abs) 0.0 x10E3/uL 0.0 0.1 02 EPSTEIN, JEFFREY 263-480-2797-0 Seq/5515 09/25/13 15:06 ET FINAL REPORT This document contains private and confidential health infamation protected by slate and federal law. If you have received this document in amt, please tall 800-631-5250 Page 2 of 6 O200S-13 Laboratory Corporation of America Holdings All Rights Reserved DOC I Ver. 1.49 EFTA01108235 LabCorp labadbaryOanaotalsolDnifx Piww%amm- EPSTEIN, JEFFREY si., on. n N., a I‘. , 263-480-2797-0 movie Ntradwi 31143092 ration In Control Month:, CNT31143092 Dam and I my CoII4% led 09/20/13 14:00 Dale Iterotkat 09/25/13 S. M l\el \ %I 0 60/08/00 I ltt, .4 Bulb 01/20/53 TESTS RESULT FLAG Comp. Metabolic Panel (14) Glucose, Serum BUN (1103 19 High) Creatinine, Serum 0.94 eGFR If NonAfricn Am 88 eGFR If Africn Am 101 BUN/Creatinine Ratio 20 Sodium, Serum 139 Potassium, Serum 4.1 Chloride, Serum 98 Carbon Dioxide, Total 19 Calcium, Serum 10.1 Protein, Total, Serum 7.3 Albumin, Serum 4.5 Globulin, Total 2.8 A/G Ratio 1.6 Bilirubin, Total 0.6 Alkaline Phosphatase, S 58 LabCorp Raritan 69 First Avenue Raritan, NJ 0RR69- R00 Phone: 877-547-6837 AST (SCOT) ALT (SGPT) PE+Interp(Rfx IFE),S Albumin Alpha-J -Globulin Alpha-2-Globulin Beta Globulin Gamma Globulin M-Spike Globulin, Total A/G Ratio Please note: Protein electrophoresis scan will follow courier delivery. Interpretation(See Below) The SPE pattern appears essentially unremarkable. Evidence of monoclonal protein is not apparent. UNITS REFERENCE INTERVAL LAB mg/dL mg/dL mg/dL mL/min/1.73 mL/min/1.73 mmol/L mmol/L mmol/L mmol/L mg/dL g/dL g/dL g/dL mg/dL IU/L IU/L High Iva 65 - 99 8 - 27 0.76 - 1.27 >59 >59 10 - 22 134 - 144 3.5 - 5.2 97 - 108 19 - 28 8.6 - 10.2 6.0 - 8.5 3.6 - 4.8 1.5 - 4.5 1.1 - 2.5 0.0 - 1.2 44 - 102 0 - 40 0 - 44 4.2 0.2 0.8 1.0 1.0 Not Observed 3.1 1.4 Lyme P.b/Western Blot Reflex Lyme IgG/IgM Ab g/dL g/dL g/dL g/dL g/dL g/dL g/dL via computer, 0.92 High index Negative Equivocal Positive Note: The CDC currently advises that Western testing be performed following all equivocal positive EIA results. Final diagnosis should appropriate clinical findings and a positive which is also positive by Western blot. 3.2 - 5.6 0.1 - 0.4 0.4 - 1.2 0.6 - 1.3 0.5 - 1.6 Not Observed 2.0 - 4.5 0.7 - 2.0 mail, or 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 0.00 - 0.90 02 <0.91 0.91 - 1.09 >1.09 blot or include EIA EPSTEIN, JEFFREY 263-480-2797-0 Seq a 5515 09/25/13 15:06 ET FINAL REPORT This document contains private and confidential health information protected by state and federal law If you have received this document in enor, please call 800-631-5250 Page 3 of 6 O2004-13 Lehman:ay Corporation of America 0 Holdings All Rights Reserved DOCI Ver. 1.49 EFTA01108236 LabQorp PateentNarne EPSTEIN, JEFFREY 263-480-2797-0 A. .ouni NIMLIVt 31143092 l'anent ID Control Number CNT31143092 laic midTune Collected 09/20/13 14:00 Dale Reported 09/25/13 fin M April rat I 60/08/00 01/20/53 LabCorp Raritan 69 First Avenue Raritan, NJ 08869-1800 I'Insne: 877-547-6837 TESTS RESIJIff FLAG UNITS RE773tENCE IWPERVAL LAB Lyme Ab Interp., EIA Lyme Ab IgG by WB: IgG P93 Ab. IgG P66 Ab. IgG P58 Ab. IgG P45 Ab. IgG P41 Ab. IgG P39 Ab. IgG P30 Ab. IgG P28 Ab. IgG P23 Ab. IgG P18 Ab. Lyme IgG WB Interp. Positive: 5 of the following Borrelia-specific bands: 18,23,28,30,39,41,45,58, 66, and 93. Negative: No bands or banding patterns which do not meet positive criteria. Lyme Ab IgM by WB: 02 IgM P41 Ab. Absent 02 IgM P39 Ab. Absent 02 IgM P23 Ab. Absent 02 Lyme IgM WB Interp. Negative 02 Note: An equivocal or positive EIA result followed by a negative Western Blot result is considered NEGATIVE. An equivocal or positive EIA result followed by a positive Western Blot is considered POSITIVE by the CIDC. Equivocal Absent Absent Present Abnormal Absent Present Abnormal Absent Absent Absent Absent Absent Negative 0 02 02 02 02 02 02 02 02 02 02 02 02 02 Positive: 2 of the following bands: 23,39 or 41 Negative: No bands or banding patterns which do not meet positive criteria. Criteria for positivity are those recommended by CDC/ASTPHLD. p23=0sp C, p41=flagellin Note: Sera from individuals with the following may cross react in the Lyme Western Blot assays: other spirochetal diseases (periodontal disease, leptospirosis, relapsing fever, yaws, and pinta); connective autoimmune (Rheumatoid Arthritis and Systemic Lupus Erythematosus and also individuals with Antinuclear Antibody); other infections (Rocky Mountain Spotted Fever; Epstein-Barr Virus, and Cytomegalovirus). Lyme Disease Ab, Quant, IgM <0.91 index 0.00 - 0.90 02 Negative <0.91 I EPSTEIN, JEFFREY 09/25/13 15:06 ET I 263-480-2797-0 I Sai#55O FINAL REPORT Page 4 of 6 This document contains private and confidential health information protected by state and federal law. If you have received this document in error. please call 800-631-5250 O2001-13 Laboratory Corporation of America 0 Holdings All Rights Reserved D0CI Ver: 1.49 EFTA01108237 LabCorp labotOlOry COFFC4/“. al AniCet p.i.o.i.m... EPSTEIN, JEFFREY .F.....i."‘",,N. 263-480-2797-0 \..,..aNwrIvr 31143092 NhouID CotwANutithct CNT31143092 ou. ml tun; con,ord 09/20/13 14:00 nu, toward 09/25/13 Sc , M %).,i ni .l ,, 60/08/00 I )ilt 'il th rill 01/20/53 LabCorp Raritan 69 First Avenue Raritan. NJ 08869-1800 PlumeArn -547 -MO7 TESTS RESULT FLAG UNITS Equivocal 0.91 - 1.09 Positive >1.09 REFERENCE INTERVAL LAS Note: IgM levels may peak at 3-6 weeks post infection, then gradually decline. FDA currently advises that Western Blot testing be performed following all equivocal or positive EIA results. Final diagnosis should include appropriate clinical findings and a positive EIA which is also positive by Western Blot. Iron and TIBC Iron Bind.Cap.ITIBC) 329 ug/dL 250 - 450 UIBC 244 ug/dL 150 - 375 02 Iron, Serum 85 ug/dL 40 - 155 02 Iron Saturation 26 % 15 - 55 Testosterone, Free+Weakly Bound Testosterone, Serum Prolactin DHEA-Sulfate Homocyst(e)ine, Plasma C-Reactive Protein, Cardiac Hemoglobin Alc 178 Low ug/dL 348 - 1197 02 4.2 ng/mL 4.0 - 15.2 02 207.7 ug/dL 51.7 - 295.0 02 **Please note reference interval change** 12.8 umol/L 0.0 - 15.0 02 1.04 mg/L 0.00 - 3.00 02 Relative Risk for Future Cardiovascular Event Low <1.00 Average 1.00 - 3.00 High >3.00 ( .15:, High % 4.8 - 5.6 02 Increased risk for diabetes: 5.7 - 6.4 Diabetes: >6.4 Glycemic control for adults with diabetes: <7.0 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum Roche ECLIA methodology. 0.8 ng/mL 0.0 - 4.0 02 According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory PSA value 0.2 ng/mL or greater. EPSTEIN, JEFFREY 263-480-2797-0 Seq45515 09/25/13 15:06 ET FINAL REPORT This document contains pnvate and confidential health information prowled by same and federal law. If you have received this dccumcnt in error. please call S00-631-5250 Page 5 of 6 02004-13 laboratory Corporation of America m Holdings All Rights Reserved DOCI Vec 1.49 EFTA01108238 LabCorp PammNow EPSTEIN, JEFFREY SpumenMMer 263-480-2797-0 A:ckvm Nombre 31143092 Diked ID Coned Number CNT31143092 Dune and him( ( nand 09/20/13 14:00 Dale NSW( Wki 09/25/13 Se\ M Apt YAM 60/08/00 flak .4 KIM 01/20/53 LabCorp Raritan 69 First Avenue Raritan. NJ 08869-1800 Phone: 877-547-6837 TESTR ItZSULT FLAG UNITS REFERENCE INTERVAL LAB Values obtained with different assay methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. TSH 1.680 uIU/mL 0.450 4.500 02 Vitamin D, 25-Hydroxy 41.4 ng/mL 30.0 - 100.0 02 Vitamin D deficiency has been defined by the institute of Medicine and an Endocrine Society practice guideline as a level of serum 25-OH vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/mL (2). 1. IOM (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press. 2. Holick MF, Hinkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. JCEM. 2011 Jul; 96(7):1911-30. Uric Acid, Serum Uric Acid, Serum 7.1 mg/dL 3.7 - 8.6 02 Please Note: 02 Therapeutic target for gout patients: <6.0 GGT 18 IU/L 0 - 65 02 Insulin High uIU/mL 2.6 - 24.9 02 Ambiguous Test Order Attempts to contact your facility to clarify an ambiguous test order were unsuccessful. Please contact the laboratory to verify the request. Specimens are (1 outinely held for 7 days from date of receipt. Ambiguous test order: A 02824 0 Ferritin, Serum 0/4. 49 AAP) 121 ng/mL 02 30 - 400 02 Request Problem Test Not Performed. Specimen is lipemic. TEST: 143257 Testost., % Free+Weakly Bound Panel: 143255 03 01 67 LipoScience Inc 2500 Sumner Blvd, Raleigh, NC 27616-3235 02 RN LabCorp Raritan 69 First Avenue, Raritan, NJ 08869-1800 03 BR LabCorp Burlington For Dir: Deanna Franke, PhD Dir: Araceli B Reyes, MD Dir: William F Hancock, MD 1447 York Court, Burlington, NC 27215-3361 inquiries, the physician may contact Branch: 800-631-5250 Labs 877-547-6837 EPSTEIN, JEFFREY 263-480-2797-0 Seg 5515 09/25/13 15:06 ET FINAL REPORT This document contains private and confidential health inferential protected by state and federal law. If you have received this document in error. please call 800-631-5250 Page 6 of 6 02004-13 Laboratory Corporation of America O Holdings All Rights Reserved DOCI Ver: 1.49 EFTA01108239 Laboratory Corporation of America Special Chemistry Department Raritan, New Jersey Serum Protein Electrophoresis Specimen Number 263480279706 Account No./Name: 31143092-Woodson Sorrell Total Protein: 7.3 DID: Patient Name: EPSTEIN,JEFFREY Account Address 1: Patient Id: Account Address 2: 44 E 67th St Birthdate: 20-JAN-1953 Account Address 3: New York, NY 10065 ,t _ SP/FE SPE Split Beta Sample 9 09-23-2013 12:45:08:08 Statua.Ok Fraction ts g/dL Range Albumin 58.1 4.2 3.2 5.6 Alpha 1 2.7 0.2 0.1 0.4 Alpha 2 11.2 0.8 0.4 1.2 Beta 13.9 1.0 0.6 1.3 Gamma 14.1 1.0 0.5 1.6 Total 7.3 6.0 8.5 Comment The SPE pattern appears essentially unremarkable. Evidence of monoclonal protein is not apparent. EFTA01108240 La b C pip SmimenNwatta 263-480-2797-1 Pawn In CoMmINum4m CNT31143092 AcemmiNmalla 31143092 AccmmIllamwNumlw 212-535-1012 RoMe 70 l'aMmIli4Nme EPSTEIN AccamlAddlmA Woodson Merrell 44 E 67th St New York NY 10065 Pamm him I Name JEFFREY Fmcm SNAIL< Nair Blum SSP ***-**-3348 Pa wag Illtom 212-772-9416 Fool VAtime Ape I WMMI 60/08/00 Usle 4 Rob 01/20/53 Sex I M ',tom', PaImm Aare. 9 E 71ST ST NEW YORK NY 10065 Atlamoft4 IMmilimam UPIN: A62553 Die aid 'rime Collectal 09/20/13 14:00 IWelted 09/25/13 Mole mai Imm Recamied 09/26/13 09:0SET PI9vam Name MERRELL , W SPI 1023153509 l'It>.4,4o ID MERRELL LabCorp Raritan 69 First Avenue Raritan, NJ 08869-1800 Phone:800-631-5250 Icd lkactril ESN and LH; Written Authorization TEST/3 RESULT FLAG UNITS RRIT.RIniCIS INTERVAL LAB FSH and LH LH 5 . 3 mIU/mL 1.7 - 8.6 01 FSH 4 . 5 mIU/mL 1.5 - 12.4 01 Written Authorization Written Authorization Received. 01 Authorization received from SIGNATURE FILE 09-25-2013 Logged by Anca Orban 01 RN LabCorp Raritan Dir: Araceli B Reyes, MD 69 First Avenue, Raritan, NJ 08869-1800 For inquiries, the physician may contact Branch: 800-631-5250 Lab: 800-631-5250 EPSTEIN, JEFFREY 263-480-2797-1 Seq a 5522 09/26/13 09:06 ET FINAL REPORT This document contains private and confidential health information protected by sum and federal law. If you have received this document in error, please call 800-631-5250 Page 1 of 1 O2004-I3 Laboratory Calash's:I of America Holdings All Rights Reserved DOCI Ver 149 EFTA01108241 LabCorp Raritan 69 First Avenue =ere; Metro'n or....cr Raritan. NJ 08869-1800 Phone 800-762-4344 N... on,,, "...mix, 263-480-3235-0 l'aNcin II) C oimol Number 04K31143092 Accous Number 31143092 Mawr Phme Nmnivr 212-535-1012 Rome 70 i.awi,i I.nt Nom: EPSTEIN A.,ouni Atkirr, Woodson Merrell 44 E 67th St New York NY 10065 I . Ilk Of IRA NJITIC JEFFREY Tabun, Mold!. N.IIIIC rancid Vol ***_**_3348 IN ICIII II me 212-772-9416 Ltd ',Iwo,. Ap: t‘Al/IN 60/08/00 %de ol limit 01/20/53 Sea M I ...ialt: l'atient Atkin.. 9 EAST 71ST ST NEW YORK NY 10065 Addonmal !Moon-mon UPIN: A62553 iiai, ari t um Collected 09/20/13 14:00 l/oc I meted 09/21/13 flaw and I mte Kt-rimed 09/26/13 09:05ET llog..13II Name MERRELL , W Nil 1023153509 Pity.Nsan ID Lp-PLA2 TESTS RESULT FLAG UNITS REFERENCE INTERVALMAS ng/mL Low Risk Moderate Risk High Risk LP -PLA2 137 131 - 199 <200 200 - 235 >235 01 01 BN LabCorp Burlington Dir: William F Hancock, MD 1447 York Court, Burlington. NC 27215-3361 For inquiries, the physician may contact Branch: 800-631-5250 Lab: 800-762-4344 EPSTEIN, JEFFREY 263-480-3235-0 SeqW5523 09/26/13 09:06 ET FINAL REPORT This document contains private and confidemial health information married by slam and federal law. If you have received this document N encl., please call 800-631-5250 Page 1 of 1 02004-13 Laboratory Corporation of America Holdings All Rights Reserved DOCI Vcr. 1.49 EFTA01108242 La pc p rp *Nm.e.N.Ove 263-480-3234-0 P.awnilD ConmAMmilin CMJ31143092 AcaluMNisiother 31143092 ho:mmillhwieNwnhci 212-535-1012 Row 70 raWsla,INam EPSTEIN AccouniAddms Woodson Merrell 44 E 67th St New York NY 10065 NwislioaName JEFFREY PativadMiddkNanow Nam SW *:*_**_3348 Pas II me 212-772-9416 Total Volture Art iT/M/DI 60/08/00 Da of Binh 01/20/53 Sr, M tawny raliall /Wan 9 EAST 71ST NEW YORK NY 10021 'VW wmunfmmimm UPIN: A62553 Mgt and Tmw Colk,ned 09/20/13 00:00 Date Enteral I 09/21/13 'haw AM Time Ikeporied 09/25/13 09:05ET Miy w Ian Name MERRELL , W NM 1023153509 Mvaicim lo LabCorp Raritan 69 First Avenue Raritan. N 08869-1800 Phonc: 800-444-9111 let thdored Dihydrotestosterone TESTS RESULT FLAG WITS REFERENCE INTERVAL LAB Dihydrotestosterone Dihydrotestosterone Reference Range: Adult Male: 30 - 85 16 Low ng/di, 01 ES Esoterix Endocrinology Dir: Samuel Pepkowitz, MD 4301 Lost Hills Road, Calabasas Hills, CA 91301-5358 For inquiries, the physician may contact branch: 800-631-5250 Lobs 000-444-9111 01 EPSTEIN, JEFFREY 263-480-3234-0 Scq N 5509 09/25/13 09:05 ET FINAL REPORT This document contains private and confidential health information protected by state and federal law. If you have received this document in env., please call 800-631-5250 Page 1 of 1 O2004-13 Laboratory Corporation of America it Holdings All Rights Reserved DOCI Ver 1.49 EFTA01108243 LMEIOS;(?11) 1.414.M1Ull p 0.421 um. 69 First Avenue Raritan. NJ 08869-1800 Mums:: 800-631-5250 'IX', IIIIi:II s. .i ., 263-042-7600-0 Paiem In Coruna Number CML31143092 Account Number 31143092 &room Maw Number 212-535-1012 Monte 70 •iin-rio .1,1 Name EPSTEIN Accident /Wm. Woodson Merrell 44 E 67th St New York NY 10065 Rmemlembnie JEFFREY Pa6cmAhMkNaux Paine Mu *** -** -3348 Patient At me 212-772-9416 heal volume /wont" I 60/08/00 Mwdffirth 01/20/53 Sc' M 'aging No Pala. Adtkr. Additicanl Ink...Mica Dare and Time Takata 09/20/13 14:00 Dar TnIered 09/21/13 Dare andline Reported 09/21/13 35:05ET ITS:lan Name NM I lbrwtan ID MERRELL Tea. (Mined Fibrinogen Activity TESTS RIBULT FLAG UNITS REFERENCE INTERVAL. LAS Fibrinogen Activity 355 mg/dL 193 - 507 Specimen was ultracentrifuged before testing to remove extreme lipemia. Results should be interpreted with caution. 01 01 RN LabCorp Raritan Dir: Araceli B Reyes, MD 69 First Avenue, Raritan, NJ 08869-1800 For inquiries, the physician may contact Branch, 800-631-5250 Labs 800-631-5250 EPSTEIN, JEFFREY 263-042-7600-0 Seq R 5484 09/21/13 15:06 ET FINAL REPORT This document contains private and confidential health information protected by state and federal law. If you have received this document in error. please call 000-631-5250 Page 1 of 1 02004-13 Laboratory Corporation of America Holdings All Rights Reserved DOCI Ver. 1.49 EFTA01108244 I.abCorp Raritan 69 First Avenue Laos, Ccipens000 of Aarwricir Raritan. N1 08869-1803 Phone. 800-631-5250 „,,, ,,,,,„ Saila, , 263-480-2784-0 Pc( i ( ci II) ( ofilnil Surolvr CMS31143092 U... wir Nuttryt 31143092 \ «, tot Pl.(cK `.(i, , it . i 212-535-1012 k., oc 70 .,men A.( Nren. EPSTEIN % c • ''"'' 'Li' r` " Woodson Merrell 44 E 67th St New York NY 10065 1'.,,,,,t I (IV Sank( JEFFREY I Pawn( Multi)' Nan MI µill SVI *** -** -3348 P. µr( rh<- 212-772-9416 TM.' Volum: Arc t I AIM) 60/08/00 laic of Mali 01/20/53 Sc• M I aunty rldwa, Mt.. Atklastrul lolommi ,on arc awl 1 tone Collo. Ertl 09/20/13 00:00 I Oak PirctrIl 09/21/13 r Dale and rum( Rory tried 09/21/13 15:osET lir •e( on I NPI I llsop...In II) MERRELL Ca+PTH Intact TESTS Ca+PTH Intact Calcium. Serum PTH, Intact Intact PTH RESULT 9.6 43 \ Interpretation FLAG Normal Primary Hyperparathyroidism Secondary Hyperparathyroidism Non-Parathyroid Hypercalcemia Hypoparathyroidism Non-Parathyroid Hypocalcemia UNITS mg/dL pg/mL REFERENCE INTERVAL Intact PTH (pg/mL) 15 - 65 >65 >65 <65 <15 15 - 65 8.6 - 10.2 15 - 65 Calcium (mg/dL) 8.6 - 10.2 >10.2 <10.2 >10.2 < 8.6 < 8.6 01 RN LabCorp Raritan Dir: Araceli B Reyes. MD 69 First Avenue, Raritan, NJ 08869-1800 For inquiries, the physician may contact Branch. S00-631-5250 Lab: 800-631-5250 List 01 01 01 EPSTEIN, JEFFREY 263-480-2784-0 Seq $t 5485 09/21/13 15:06 ET FINAL REPORT This document cunuins private and confidemial health information protected by state and Iedenl law. If you have received this document in error please call 800-631-5250 Page 1 of 1 O1004-B Laboratory Corporation of America CO Holdings All Rights Reserved DOCI Vet 1.49 EFTA01108245 LabCojp Spe.OnegNifogia 263-480-3346-0 Pmecilll ConoolNionbef CMH31143092 1- AccogaNuagia 31143092 AmotueMmerNuellire 212-535-1012 Wow 70 'men >4 Nm,, EPSTEIN Acvoo Adam Woodson Merrell 44 E 67th St New York NY 10065 PsiemlifoNsine JEFFREY rmicoladialcNmw NfiewSM ***-**-3348 PolomMio: 212-772-9416 TotalVolow Age i YAM i 60/08/00 Mee of Both 01/20/53 Se, M Fau1g No PmfeleMdfn AddaioluMMmmm,o MilemWTthtel'aemed I 09/20/13 14:00 Daielamml 09/21/13 I Mocamitsofeltcpmed 09/23/13 09:05ET ItywooNmioe NM MlywierflO MERRELL LabCorp Raritan 69 First Avenue Raritan, NJ 08869-1800 Phone: 800-7 froothtlesed IGF-1 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB IGF-1 Insulin-Like Growth Factor I 127 ng/mL 51 - 194 01 01 BN LabCorp Burlington Dir: William F Hancock, MD 1447 York Court, Burlington, NC 27215-3361 For inquiries, the physician may contact Samba 800-631-6250 Labs 800-762-4344 EPSTEIN, JEFFREY 263-480-3346-0 Seq N 5489 09/23/13 09:05 ET FINAL REPORT This document contains private and confidential health information protected by state and federal law. If you have received this document in arm please call 800-631-5250 Page 1 of 1 02001-11 Laboratory Corporation of America S Holdings All Rights Reserved DOC I Ver. 149 EFTA01108246